Goelzer Investment Management, Inc. Viatris Inc Transaction History

Goelzer Investment Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$9.95 - $12.27 $228,521 - $281,805	-22,967 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$9.81 - $15.4 $1.88 Million - $2.95 Million	-191,238 Reduced 89.28%	22,967 $250,000
Q4 2021 Feb 11, 2022	SELL	$12.09 - $14.68 $348,518 - $423,180	-28,827 Reduced 11.86%	214,205 $2.9 Million
Q3 2021 Oct 29, 2021	SELL	$13.25 - $15.13 $217,909 - $248,827	-16,446 Reduced 6.34%	243,032 $3.29 Million
Q2 2021 Aug 12, 2021	SELL	$12.97 - $16.15 $34,370 - $42,797	-2,650 Reduced 1.01%	259,478 $3.71 Million
Q1 2021 May 06, 2021	SELL	$13.59 - $18.54 $70,586 - $96,296	-5,194 Reduced 1.94%	262,128 $3.66 Million
Q4 2020 Feb 12, 2021	BUY	$14.3 - $18.74 $3.82 Million - $5.01 Million	267,322 New	267,322 $5.01 Million

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Goelzer Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Goelzer Investment Management, Inc. with notifications on news.